GlycoNex Of Taiwan, Otsuka Pharma Open Colorectal Cancer Drug Trials
This article was originally published in PharmAsia News
Executive Summary
Taiwan's GlycoNex said it has plans to develop a drug in at least once every three years to follow on its recent beginning of clinical trials in Japan of its GNX-8, an antibody for treating colorectal cancer.